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that render individuals susceptible to cutaneous melanoma, but
further work is required to dissect out whether MC1R variants in
melanoma act independently of the skin type phenotype.
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Reply
Healy et al raise some interesting points in their letter regarding the
importanceof polymorphism in themelanocortin1 receptor (MCIR)
and its association with skin type, hair color, and susceptibility to
melanoma. We have been studying putative associations between
polymorphic candidate genes and susceptibility to skin cancer. We
have identified allelic variants at several loci that are associated with
multiple basal cell carcinomas or a shorter time from first to second
presentation (Lear et al, 1996). In some cases, we identified inter-
actions between genotypes and skin type 1 that were associated with
a worst clinical outcome. Accordingly, the Valverde et al (1995) study
showing a particularly strong association between allelic variants at
the MC1R and red hair and skin type 1 was of considerable interest
as a candidate for cutaneous cancers. We initially looked at three of
the described alleles, Val92Met, Asp294His, and Asp84Glu, in
patients with melanoma. We selected these from the nine alleles
described because Val92Met and Asp294His appeared to be relative
common and Asp84Glu had been associated with susceptibility to
melanoma in a small case control study (Valverde et al, 1996). We
studied 306 melanoma cases and 190 controls and attempted to show
associations between alleles and skin type and hair color in both
groups. In the case group we attempted to also demonstrate differ-
ences in allele frequency with tumor type and site (Ichii-Jones et al,
1998).
We failed to confirm the strong association between allelic variants
and skin type reported by Valverde et al (1995). None the less, in the
control group we did identify a significant association between skin
type and a group comprising all the controls with any one or more
of the three alleles studied. Thus, although we did not find the strong
association previously reported for individual alleles, our data do
support the view that allelic variation at the MC1R is associated
with skin type. Importantly, this association was not evident in the
melanoma case group.
Healy et al also comment on the association between MC1R allelic
variants and hair color. They report that three variants – Arg151Cys,
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Arg160Trp, and Asp294His – are strongly associated with red hair.
The data presented in our study also indicate that Asp294His is
associated with red hair in both controls and melanoma cases. This
association only approached statistical significance (p 5 0.10) in our
study (Ichii-Jones et al, 1998). We believe this reflects the relatively
small number of red-haired subjects that we were able to recruit.
Further studies in a larger patient group have shown a statistically
significant association between this allele and red hair.
Overall therefore, we find the association between MC1R alleles
and skin type to be less strong than reported by Valverde et al (1995).
We agree that Asp294His (but not Val92Met or Asp84Glu) are associ-
ated with red hair. We note the suggestion of Healy et al that the
discrepancies between our data and theirs might result from our
inability to properly classify patients as skin type 1 or having red
hair. All classifications of skin type were carried out by experienced
dermatologists and, anyway, there is general agreement in the literat-
ure that classifying patients as skin types 1 or 4 is straightforward
(Kricker et al, 1993). Admittedly distinguishing between types 2 and
3 is more problematical. Importantly, in previous studies in patients
with skin cancer we have invariably shown expected associations
between skin type and clinical outcome (Lear et al, 1996). Similarly,
classifying patients as having red hair is straightforward though we
accept that the use of standardized charts will help distinguish different
shades of red.
The second part of the letter from Healy et al refers to our failure
to identify associations between the three alleles studied and suscepti-
bility to melanoma. We are not claiming that the MC1R gene is not
involved in the pathogenesis of melanoma. Indeed, in the discussion
of our paper we stated that ‘‘other allelic variants (possibly some yet
unidentified) may be important’’. Assessing a candidate gene that
demonstrates a relatively large number of alleles is difficult. In our
experience large numbers of cases and controls are needed to firstly,
assess a susceptibility candidate and secondly, determine whether the
gene has any influence on outcome. The influence of most candidate
genes so far described is modest (odds ratios about 2–3). Accordingly,
our aim has been to identify within case groups, subgroups of patients
who are described by particular genotypes and in whom the associ-
ation between genotypes and susceptibility or outcome is much
stronger (Lear et al, 1996). Even with a relatively large study group
(190 controls and 306 melanoma cases), it was difficult to assess
associations between MC1R alleles and host characteristics. Clearly,
larger study groups are needed. These will make sequencing of the
entire gene expensive and, anyway, many allelic variants will be very
rare and/or will have no obvious functional consequence. Assessing
the functional implications of alleles is not always straightforward if
the function of the gene is unclear. Thus, whilst we do not disagree
that sequencing is an important option, screening of selected alleles
in large study groups remains a useful approach. Experiments to assess
function can then be focused on alleles shown to be important in
molecular epidermologic studies.
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